About Kantonsspital Baselland - Standort Liestal
Das Kantonsspital Baselland ist eine Anstalt des öffentlichen Rechts des Kantons Basel-Landschaft und entstand im März 2012 durch Zusammenlegung des Kantonsspitals Liestal, des Kantonsspitals Laufen und des Bruderholzspitals in Binningen.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
2
University Hospital, Basel, Switzerland
1
Clinical Trials at Kantonsspital Baselland - Standort Liestal
During the past decade, Kantonsspital Baselland - Standort Liestal conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Advantageous Predictors of Acute Coronary Syndromes Evaluation (APACE) Study
2006-04-01
2025-06-01
Recruiting
10,000
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
2022-07-25
2027-02-01
Recruiting
440
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Metastatic Triple-Negative Breast Cancer
2022-07-20
2027-05-01
Recruiting
540
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kantonsspital Baselland - Standort Liestal"
#1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Swiss National Science Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Kantonsspital Baselland - Standort Liestal
According to Clinical.Site data, the most researched conditions in "Kantonsspital Baselland - Standort Liestal" are
"Triple Negative Breast Cancer" (2 trials), "Angina, Unstable" (1 trials), "Myocardial Infarction" (1 trials), "PD-L1 Negative" (1 trials) and "PD-L1 Positive" (1 trials). Many other conditions were trialed in "Kantonsspital Baselland - Standort Liestal" in a lesser frequency.
Clinical Trials Intervention Types at Kantonsspital Baselland - Standort Liestal
Most popular intervention types in "Kantonsspital Baselland - Standort Liestal" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials), "Sacituzumab Govitecan-hziy" (2 trials) and "nab-Paclitaxel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Kantonsspital Baselland - Standort Liestal
The vast majority of trials in "Kantonsspital Baselland - Standort Liestal" are
3 trials for "All" genders.
Clinical Trials Status at Kantonsspital Baselland - Standort Liestal
Currently, there are NaN active trials in "Kantonsspital Baselland - Standort Liestal".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Kantonsspital Baselland - Standort Liestal,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kantonsspital Baselland - Standort Liestal, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".